Here we examined whether the Matsuda-DeFronzo insulin sensitivity index (ISI-M) is more efficient than the homeostasis model assessment of insulin resistance (HOMA-IR) for assessing risk of hypertension. Cross-sectional and longitudinal analyses were conducted using normotensive subjects who were selected among 1399 subjects in the Tanno-Sobetsu cohort. In the cross-sectional analysis (n ¼ 740), blood pressure (BP) level was correlated with HOMA-IR and with ISI-M, but correlation coefficients indicate a tighter correlation with ISI-M. Multiple linear regression analysis adjusted by age, sex, body mass index (BMI) and serum triglyceride level (TG) showed contribution of ISI-M and fasting plasma glucose, but not of HOMA-IR. In the longitudinal analysis (n ¼ 607), 241 subjects (39.7%) developed hypertension during a 10-year follow-up period, and multiple logistic regression indicated that age, TG, systolic BP and ISI-M, but not HOMA-IR, were associated with development of hypertension. In subjects o60 years old, odds ratio of new-onset hypertension was higher in the low ISI-M group (ISI-M, less than the median) than in the high ISI-M group for any tertile of BMI. In conclusion, ISI-M is a better predictor of hypertension than is HOMA-IR. Non-hepatic IR may be a determinant, which is independent of TG, BP level and BMI, of the development of hypertension.
Introduction
Hypertension, diabetes and dyslipidemia are lifethreatening risk factors of cardiovascular events worldwide [1] [2] [3] [4] and these lifestyle-related diseases tend to co-exist in the same individuals. [5] [6] [7] Insulin resistance (IR) is not only a hallmark of type 2 diabetes mellitus and metabolic syndrome but also frequently present in non-diabetic patients with hypertension. Accumulating evidence to date indicates that IR significantly contributes to accelerated atherosclerosis and development of cardiovascular events. [8] [9] [10] [11] [12] However, in contrast to its role in atherosclerosis, the role of IR in development of hypertension remains unclear. Acute hyperinsulinemic glucose clamp has been shown to induce sodium retention and activation of the sympathetic nervous system and renin-angiotensin system in humans. [13] [14] [15] However, results regarding the association of IR with hypertension in previous population studies are inconsistent. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Although the inconsistency cannot be easily explained, use of different indices for assessment of IR might be responsible for the apparent contradiction between results of earlier studies. Insulin resistance in skeletal muscle is thought to contribute to the development of hypertension. [26] [27] [28] [29] [30] [31] On the other hand, recent studies have shown that IR can occur separately in the liver and in skeletal muscles. 32 Current clinical indexes of insulin sensitivity (IS) are not specific to IS in the liver or that in the skeletal muscle.
The aim of the present study was to determine whether the Matsuda-DeFronzo index (ISI-M) 33 is a better predictor of hypertension than the homeostasis model assessment of IR (HOMA-IR). 33 To this end, we performed both a cross-sectional analysis and a longitudinal analysis using the same Japanese cohort, Tanno-Sobetsu cohort. 12, [34] [35] [36] [37] HOMA-IR 38 is easily calculated from fasting insulin and glucose levels and has thus been used in numerous clinical and epidemiological studies. However, this index basically represents IS of the liver and possibly underestimates IR of the skeletal muscle. On the other hand, ISI-M incorporates plasma insulin and glucose levels after oral glucose loading, both of which depend on not only hepatic but also skeletal glucose disposition. We postulated that IR detected by ISI-M is more closely associated with elevation of blood pressure (BP) than is that by HOMA-IR. Results of the present study suggest that ISI-M is a better index of IR in terms of prediction of newonset hypertension and that its contribution to development of hypertension is independent of serum triglyceride (TG) and BP level per se.
Subjects and methods

Study subjects
The protocol of the present study was approved by the Ethics Committee of Sapporo Medical University, and all of the study subjects gave informed consent for inclusion in the present investigation.
A total of 1399 residents of the towns of Tanno and Sobetsu in Hokkaido, Japan, who underwent health examinations in 1991 or 1992, (Residents of Tanno and those of Sobetsu attended the examinations in 1991 and 1992, respectively.) participated in the present protocol. To examine the relationship between IR and new-onset hypertension, we excluded subjects receiving treatment for hypertension, diabetes or dyslipidemia and those with untreated hypertension at the baseline examination. Hypertension was defined by criteria described below (BP determination and diagnosis of hypertension). An additional 10 subjects whose serum TG level at the baseline examination was 4400 mg dl À1 were excluded, because that level of TG makes calculation of low-density lipoprotein cholesterol (LDL-C) concentration, by use of the Friedewald equation, invalid. 39 After the exclusion, 740 subjects remained and their data were used for crosssectional analyses in the present study.
The study cohort was followed up by biannual health examinations, and data at 10 years after the baseline examination (that is, data in 2001 or 2002) were used for longitudinal analyses of new onset of hypertension and associated factors. As 133 subjects did not show up to receive a health examination at the 10-year follow-up, data from 607 subjects (254 males and 353 females, aged 57.6 ± 10.3 years) were used for the longitudinal analysis.
Blood pressure determination and diagnosis of hypertension After a 5-min rest, BP was measured twice in the sitting position using a mercury sphygmomanometer. Patients were advised to refrain from smoking before BP determination and blood sampling. The average of two measurements was used for analysis. Subjects with systolic BP (SBP) X140 mm Hg and/or diastolic BP (DBP) X90 mm Hg or those who were treated for hypertension were defined as individuals with hypertension. This definition was used for diagnosis of hypertension at the baseline examination and during a 10-year follow-up. Information on medications, which study subjects were taking, was thoroughly collected by public nurses.
Oral glucose tolerance test and blood analyses
In the morning after a 10-to 12-h overnight fast, all participants underwent a 75-g oral glucose tolerance test (OGTT). Blood samples were taken for the determination of plasma glucose and insulin concentrations before and at 60 and 120 min after taking 75 g glucose solution (TRELAN-G75, 225 ml, Ajinomoto Pharmaceutical Co. Ltd., Tokyo, Japan). Plasma glucose and insulin levels were measured using the glucose oxidase method and the RIA beads method (Dainippon Sumitomo Pharma, Osaka, Japan), respectively. Fasting levels of serum total cholesterol, high-density lipoprotein-cholesterol and TG were determined by the cholesteroloxidase-dimethoxy-aniline hydroxy-3-sulfopropyl (DAOS) method, dextran-sulfate magnesium-hydrochloride precipitation method and glycerol-3-phosphate-oxidase-DAOS method, respectively. LDL-C was calculated from the Friedewald equation. 
Indices of insulin resistance
Statistical analysis
Statistical analyses were conducted using JMP software version 7.0.1 for Windows (SAS Institute, Cary, NC, USA) and SPSS ver.12.0J for Windows (SPSS, Chicago, IL, USA). Numerical values are presented as means ± s.d.'s. Pearson correlation coefficient was calculated to evaluate correlations between the two variables. Differences in parameters between two study groups were tested by use of the unpaired t-test. The Meng-Rosenthal-Rubin method was used for testing difference in correlation coefficients between HOMA-IR and BP and those between ISI-M and BP. In cross-sectional analysis of the data, multiple linear regression analysis was carried out to assess the relationships between BP and IR indices. In longitudinal analysis of the data, odds ratio (OR) of new-onset hypertension was calculated by multiple logistic regression analysis. The w 2 -test was used for analyzing trend of incidence of hypertension across quartiles of HOMA-IR or ISI-M and between subgroups of HOMA-IR or ISI-M. Because of the skewed distribution of data, natural logarithmic transformation was performed for glucose concentrations, insulin concentrations, HOMA-IR, ISI-M, and TG, high-density lipoprotein-cholesterol and LDL-C levels for regression analysis. P-values o0.05 were considered to be statistically significant.
Results
Cross-sectional analyses Baseline characteristics of the study subjects are shown in Table 1 . There was no significant difference between the male and female subjects in body mass index (BMI), HOMA-IR or ISI-M (P ¼ 0.9, 0.7 and 0.06, respectively), whereas levels of highdensity lipoprotein-cholesterol and LDL-C were lower, and TG level was higher in the male subjects than in the female subjects. BMI values were low by Western standards but were comparable with BMI values in earlier population studies in Japan. 40, 41 As shown in Figure 1 , both SBP and DBP were significantly correlated with HOMA-IR (r ¼ 0.12 and r ¼ 0.21, Po0.01 for both) and with ISI-M (r ¼ À0. 18 and r ¼ À0.25, Po0.01 for both). However, absolute values of correlation coefficients were significantly larger for ISI-M than for HOMA-IR (by Fisher's ztransformation; z values ¼ 5.21 and 7.40 for SBP and DBP, respectively). SBP had significant correlation also with the level of fasting plasma glucose (FPG) (r ¼ 0.16, Po0.0001), plasma glucose at 120 min after glucose loading (r ¼ 0.19, Po0.001), fasting plasma insulin (FPI) (r ¼ 0.09, P ¼ 0.02) and plasma insulin at 120 min after glucose loading (r ¼ 0.11, P ¼ 0.004). In multiple linear regression analysis adjusted by age, sex, BMI and TG (Table 2) , there was a weak association between SBP and ISI-M, but there was no significant association between SBP and HOMA-IR. A stronger association was observed between DBP and both ISI-M and HOMA-IR. A significant contribution to SBP and/or DBP variations was detected also for fasting plasma glucose, plasma glucose at 120 min after glucose loading and FPI but not for plasma insulin at 120 min after glucose loading. Table 3 shows a comparison of baseline parameters between subjects who developed hypertension during the 10-year follow-up period and those who remained normotensive during the follow-up period. New-onset hypertension during the follow-up period was observed in 241 subjects (39.1% of total subjects). Subjects who developed hypertension were significantly older and their BMI, SBP, DBP, LDL-C, plasma glucose at 120 min after glucose loading and FPI levels were higher at baseline examinations compared with those who remained normotensive. However, baseline plasma level of plasma insulin at 120 min after glucose loading was not different between the two groups. Both HOMA-IR and ISI-M indicate lower IS at the baseline examination in subjects who developed hypertension during the follow-up period than in those with normal BP. In contrast to elevation of SBP and DBP, changes in BMI and TG during the 10-year follow-up period were not different between the group of subjects with new-onset hypertension and the group of normotensives (Table 3) . After adjustment for both age and sex, the difference in baseline HOMA-IR between the two groups was statistically insignificant, though inter-group differences in baseline ISI-M, BMI, SBP, DBP, FPI, DSBP and DDBP remained significant. To examine the relationship between level of IR and risk of hypertension, we compared incidences of hypertension during the 10-year follow-up in Figure 2a , there was no significant difference in hypertension incidence between HOMA-IR subgroups. In contrast, incidences of hypertension were significantly higher in lower quartiles of ISI-M than in higher ISI-M quartiles (Figure 2b ). Multiple logistic regression analysis was used to identify factors significantly involved in the development of hypertension during the 10-year followup period. By use of the stepwise method, age, sex, TG and SBP, ISI-M, HOMA-IR and BMI were selected as independent variables from parameters that were significantly different between the groups with and without hypertension (Table 3) for the multiple logistic regression analysis. As IS is closely related to BMI, we used a model with an index of IS without BMI and a model with both an index of IS and BMI. In model 1, an index of IR (that is, ISI-M or HOMA-IR), age, sex, TG and SBP were used as independent variables. In model 2, BMI was added to independent parameters incorporated into model 1 (Table 4) . In model 1, ISI-M was significantly associated with development of hypertension (P ¼ 0.029, b ¼ À0.37) as were TG and SBP, whereas a significant association of HOMA-IR with hypertension development could not be demonstrated. In model 2, significant association with hypertension was detected for age, TG, SBP and BMI but not for ISI-M or HOMA-IR.
Longitudinal analyses
As the regression dilution bias (that is, 'flattening' of the slope of the line describing the relation between an exposure variable and an outcome of interest by random measurement error in the exposure variable) might have underlain the lack of association between ISI-M and hypertension in model 2, we assessed the effects of IR on risk of hypertension development in different levels of BMI. Considering the effect of baseline age on hypertension development (Table 2) , we first divided subjects into a group of o60 years old and a group of X60 years old and then subjects in each age group were further divided by 3 Â 2 factors (tertile of BMI and high or low IS) as shown in Figure 3 . To divide subjects into insulin-sensitive and -insensitive subgroups, HOMA-IR of 1.73 and median value of ISI-M were used as cutoff values. The value of HOMA-IR (that is, 1.73) was based on our previous studies showing that HOMA-IR 41.73 predicts IR defined by the M-value determined by euglycemic glucose clamp (M o167.3 mg m À2 per min) and that by insulin levels during 75-g OGTT. 35, 36 As shown in Figure 3a , in subjects o60 years old, increase in OR of hypertension by IR was indicated in the first and third tertiles of BMI. However, such an effect of BMI 
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on OR of hypertension was not detected in subjects X60 years old (Figure 3b) . Interestingly, increased OR of hypertension in low ISI-M groups o60 years old was consistently observed for any level of BMI tertiles (Figure 3c ). In subjects X60 years old, influence of IR on OR of hypertension was not shown by ISI-M, regardless of BMI level (Figure 3d ).
Discussion
The contribution of IR to development of hypertension has been assessed in several cross-sectional and longitudinal studies in the past two decades. However, significant association of IR with development of hypertension has not been consistently demonstrated either by cross-sectional studies or by longitudinal studies. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Use of different indices for assessment of IS is one of the possible reasons for the inconsistent results of earlier studies. Currently, several indices are used for determination of IR in human subjects: M-values determined by various types of glucose clamp, HOMA-IR, ISI-M, quantitative IS check index, K ITT (an index determined by intravenous insulin tolerance test), FPI, SIRI (that is, sum of plasma insulin levels during 75-g OGTT), Belfiore index and Cederholm index. [42] [43] [44] 
33
In the present study, we found that ISI-M correlates more significantly with BP than does HOMA-IR in cross-sectional analysis (Figure 1) , and cumulative incidence of hypertension was higher in subjects with lower ISI-M (Figure 2) . Furthermore, multiple logistic regression analysis indicated that ISI-M, but not HOMA-IR, was contributory to the development of hypertension during the 10-year follow-up period. HOMA-IR represents primarily IS of the liver, as the liver is responsible for 475% of endogenous glucose production. On the other hand, ISI-M represents IS of the whole body (that is, liver and skeletal muscles) and it more closely correlates with the M-value than does HOMA-IR. 33, 45 Taken together, the present findings suggest that extra hepatic IR has a significant role in the development of hypertension. We did not selectively assess contribution of skeletal muscle IS to development of hypertension in the present study. However, this issue may be examined in future projects by use of the Cederholm index and/or a recently devised index of skeletal muscle IS (that is, the rate of plasma glucose concentration decay from its peak to its nadir during the OGTT divided by the mean plasma insulin concentration). 46 Difference in characteristics of subjects (that is, race and proportions of females and/or obesity) recruited to the studies is also a possible reason for inconsistent association of IR with hypertension in the literature. We performed a post hoc analysis to examine gender difference in the correlation of ISI-M or HOMA-IR with BP and in the relationship between level of ISI-M or HOMA-IR and incidence of new-onset hypertension. However, a significant difference was not detected between male and female subjects in any of the relationships. This lack of gender difference might be attributable to the relatively advanced age of female subjects at entry to the present follow-up study. The mean age of female subjects was 56.8 ± 10.2 years and the majority of them were post-menopausal at entry. Thus, effects of estrogens on IS and BP might not have been predominant and detectable in the present female cohort.
The contribution of obesity and that of IR to hypertension are very difficult to assess separately as obesity is a major factor leading to the development of IR and obesity per se activates multiple mechanisms of BP elevation, including stimulation of the central sympathetic nervous system. 5, [47] [48] [49] Thus, the finding that association of ISI-M with new-onset hypertension in the multiple logistic regression analysis was lost by incorporating BMI as a dependent variable (Table 4) does not necessarily exclude the possibility that IR per se contributes to the development of hypertension. In fact, OR of hypertension was higher in a subgroup with lower ISI-M than in a subgroup with higher ISI-M for each tertile of BMI in subjects o60 years old (Figure 3 ), whereas higher BMI was associated with higher OR of hypertension. Recently, Bonora et al. 25 reported that the M-value determined by hyperinsulinemiceuglycemic clamp was significantly associated with BP level after adjustment of age, sex, FPI and BMI in a cross-sectional analysis of 1093 subjects. On the other hand, such a BMI-independent association of IR with BP was not found in a similar cross-sectional analysis by Ferrannini et al. 24 In those cross- sectional studies, mean BP levels were within normal ranges, and the impact of IR on BP might be difficult to detect in subjects with normal ranges of BP. Nevertheless, the observations in a study by Bonora et al. 25 and our results presented in Figure 3 suggest obesity-independent contribution of IR to hypertension.
Increased renal sodium retention, enhanced activation of sympathetic nerve activity and reninangiotensin system, endothelial dysfunction and microvascular remodeling have been proposed as possible mechanisms of elevation of BP by IR. 5, [13] [14] [15] [47] [48] [49] [50] However, the contribution of any of these mechanisms has not yet been unequivocally demonstrated in human subjects. Acute hyperinsulinemia, induced by insulin infusion, has been shown to reduce urinary sodium excretion and to increase plasma norpeinephrine and renin activity, but it does not consistently elevate BP. [51] [52] [53] [54] In canine models, with and without obesity or renal insufficiency, not only acute but also chronic infusion of insulin failed to elevate BP, though it induced transient renal sodium retention. 51, 52 In contrast, insulin infusion in salt-sensitive rats reportedly induced hypertension with augmented sodium retention, whereas BP was not changed by insulin in salt-resistant controls. 54 Interestingly, a recent clinical study showed that sodium reabsorption in proximal renal tubules was significantly elevated in subjects with IR and obesity. 55 Furthermore, Bonora et al. 25 showed that IR, but not hyperinsulinemia, was associated with elevation of BP in non-diabetic subjects. Taken together, these observations support the notion that reduced IS in the kidney, which modifies a set point of pressure natriuresis, has a more predominant role in BP elevation by IR than does hyperinsulinemia. This notion is consistent with the present findings that ISI-M was a better predictor than HOMA-IR and plasma insulin levels ( Table 3) .
As a limitation in this study, we cannot totally exclude the possibility of bias in results because of exclusion of subjects from data analyses. We excluded 47% of subjects in the Tanno-Sobetsu cohort based on exclusion criteria, and 18% of the subjects initially included in the cross-sectional analysis dropped out during the 10-year follow-up period. However, it is unlikely that such bias, if any, is substantial for two reasons. First, baseline characteristics of subjects used for the analyses (Table 1 ) are comparable to those reported for apparently healthy populations in Japan. 50, 55 Second, baseline parameters in subjects used for the longitudinal analysis were similar to those for the cross-sectional analysis.
In conclusion, ISI-M is a better index of IR relevant to BP elevation than is HOMA-IR, and lower ISI-M in non-elderly subjects is associated with higher risk of hypertension, regardless of BMI level. These findings support the notion that IR in skeletal muscle has a significant role in the development of hypertension.
